13-14th of February, GPX Medical exhibited at neonatal intensive care conference 2ndLAUNCH in Paris, France.

GPX Medical’s CEO Hanna Sjöström discussed the need for continuous lung monitoring of preterm born infants with Prof. De Luca, President Elect European Society for Pediatrics and Neonatal Critical Care, Prof. Sriram at University of Chicago, Nadya Yousef and 350 other neonatologist from over 40 countries dedicated to improve the care of preterm born infants.

GPX Medical’s medical device for continuous lung monitoring, NEOLA, received great interest from the neonatal intensive care community and show that there is a clear need for the product.

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB (publ)
Ideon Science Park
Scheelevägen 27
223 63 Lund

Organization number: 559069-9012